Utility of cardiac troponin I, creatine kinase-MB(mass), myosin light chain 1, and myoglobin in the early in-hospital triage of "high risk" patients with chest pain.
OBJECTIVE
To evaluate the use of cardiac troponin I (cTnI), creatine kinase-MB(mass) (CK-MB(mass)), myosin light chain 1 (MLC 1), and myoglobin in identifying "high risk" patients with chest pain who will experience serious cardiac events (SCEs) in hospital.


METHODS
Prospective study.


METHODS
University affiliated medical centre in Philadelphia, USA.


METHODS
208 patients with chest pain, at > 7% risk of acute myocardial infarction (MI), but without new ST segment elevation on their presenting ECG.


METHODS
cTnI, CK-MB(mass), MLC 1, and myoglobin concentrations were obtained on admission (0 hour) and at 4, 8, 16, and 24 hours.


METHODS
The sensitivity, specificity, positive and negative predictive value, and pre- and post-test probabilities of patients suffering an SCE in hospital were determined. SCEs included cardiac death, acute MI, cardiac arrest, life threatening cardiac arrhythmia, cardiogenic shock, and urgent coronary revascularisation.


RESULTS
Admission concentrations of all markers were poor predictors of SCEs in hospital but improved substantially at subsequent timepoints. cTnI and CK-MB(mass) were consistently the most useful prognostic indicators. If both were negative at 0, 4, and 8 hours, then 99% (95% confidence interval 96% to 100%) of patients remained free from SCEs. The only SCEs not thus predicted were revascularisation procedures and associated complications. Additional tests after 8 hours, or the inclusion of additional markers, did not improve predictive accuracy further.


CONCLUSIONS
Patients with high risk clinical features on admission who have negative cTnI and CK-MB(mass) concentrations at 0, 4, and 8 hours later have a favourable in-hospital prognosis and could be considered for early triage out of coronary care units.
Hillis
G S
GS
Department of Emergency Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Zhao
N
N
Taggart
P
P
Dalsey
W C
WC
Mangione
A
A
D015415:Biomarkers / Q000097:blood; D002637:Chest Pain / Q000209:etiology*; D003325:Coronary Care Units; D003402:Creatine Kinase / Q000097:blood*; D004562:Electrocardiography; D006801:Humans; D007527:Isoenzymes; D009124:Muscle Proteins / Q000097:blood*; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis*; D009211:Myoglobin / Q000097:blood; D018994:Myosin Light Chains / Q000097:blood; D011237:Predictive Value of Tests; D011446:Prospective Studies; D014218:Triage; D019210:Troponin I / Q000097:blood
D015415:Biomarkers; D007527:Isoenzymes; D009124:Muscle Proteins; D009211:Myoglobin; D018994:Myosin Light Chains; D019210:Troponin I; D003402:Creatine Kinase